(IN BRIEF) Sandoz, a global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to acquire worldwide product rights for leading systemic antifungal agent Mycamine® (micafungin sodium, Funguard® in Japan) from Astellas. This acquisition will reinforce Sandoz’s hospital … Read the full press release →
Posted in Business, Healthcare, News, Pharma & Biotech, Switzerland
Tagged acquisition, anti-infectives, antifungal, antimicrobial resistance, Astellas, cephalosporins, echinocandin, Funguard®, generic antibiotics, GSK, micafungin sodium, Mycamine®, Nicholas Adomakoh, Richard Saynor, Sandoz